#HappyFriday Delighted for LEP Biomedical to win the "Best Use of Technology" category at this years #Irish@PharmaAwardsIRL !!
Fantastic to see our #3Dprinting led approach to ocular and #glaucoma drug delivery being recognized. ๐
Thanks to the organizers for a great event!
Delighted to see this filed. This work represents another standalone #patent that further enhances our proprietary #glaucoma#drugdelivery platform HyaGuard! ๐ฌ
@Alan Hibbitts CEO of @LepBiomedical celebrates winning the 2024 Medtech Focused Startup Silver Award, sponsored by @Furthr_ie.
"It was a fantastic experience and an opportunity to refine our business plan and pitch in front of industry leaders"
Apply now: https://t.co/E6mdcC9l0h
#HappyFriday. We are delighted to make the shortlist in the "Best Use of Technology" category at the Pharma Industry Awards 2025 here in Ireland! ๐๐ฎ๐ช๐ฌ
#PharmaAwardsIRL
Shortlist | Pharma Industry Awards 2025
Absolutely thrilled to win the #pharma category at the Top 100 Most Ambitious Companies 2025 event in Dublin last night. ๐ ๐
Thanks to all who supported our mission to drastically improve outcomes for #glaucoma surgical patients.
Huge thanks @Sparkcrowdfund for organising.
LEP Biomedical listed as one of ๐ข IRELAND'S TOP 100 MOST AMBITIOUS COMPANIES 2025! ๐ ๐๐ฎ๐ช
Delighted to see our mission to create a drop-free, solution to post-op inflammation in #glaucoma noted in a publication that covers all sectors of the #Irish#startup and ecosystem!
**IRELAND'S TOP 100 MOST AMBITIOUS COMPANIES**
- JUST UNVEILED.
Celebrating innovation, resilience, and the visionary spirit driving Ireland's business landscape. Discover the trailblazers shaping our future!
Please **RE-POST**.
https://t.co/ufhjTXCNmN
Hugely proud to win silver at this year's awards!
Congrats and thanks to all our team and advisors for helping us as we aim to move the dial on post-op #glaucoma care.
Thanks @StartupsIreland for a great competition!
#NSA2024#startup#Innovation
Good morning #EGS2024!
Please drop by this morning from 10.30 at P3.021 to see how we aim to address the underlying cause of many failures in #glaucoma drainage surgeries!
HyaGuard aims to eliminate the need for MMC and drops to give better outcomes and happier patients!
We had a super few days at the #FHSummit24 and were delighted to be selected as one of the final 3 for their #Innovation Award. Congrats @CymanticMedical especially to winner @Intheliatx!
Pitches of the Innovation Award shortlisted candidates:
@LepBiomedical LEP Biomedical is a pre-clinical stage drug-device spinout. Making Glaucoma drainage surgeries 100% successful.
#FHSummit24@InvestnetEvents
We're absolutely delighted to be shortlisted! Fantastic to see the broad interest in our mission to ensure outcomes in #glaucoma and #ophthalmic surgeries using our HyaGuard๏ฟฝ๏ฟฝ controlled #drugdelivery platform. Congrats also to all our fellow shortlisted companies!๐๐ฎ๐ช๐
LEP Biomedical announced pre-seed funding of โฌ100,000 ($107,000) over two 6-month periods, which the company says will allow for further preclinical milestones in the development of the HyaGuard platform. https://t.co/1p9ZpDCsnb